 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE--Kezar Life Sciences, Inc. Nasdaq: KZR, a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced its Co-founder and Chief Scientific Officer, Christopher Kirk, will participate in the Novel Targets for Autoimmune Diseases panel discussion at William Blairs Biotech Focus Conference on Thursday, July 15, 2021, at 11:00 a.m. ET. A live webcast of the panel 